Clinically Serious Hypoglycemia Is Rare and Not Associated With Time-in-range in Youth With New-onset Type 1 Diabetes.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
21 10 2021
Historique:
received: 02 04 2021
pubmed: 16 7 2021
medline: 15 12 2021
entrez: 15 7 2021
Statut: ppublish

Résumé

Early initiation of continuous glucose monitoring (CGM) is advocated for youth with type 1 diabetes (T1D). Data to guide CGM use on time-in-range (TIR), hypoglycemia, and the role of partial clinical remission (PCR) are limited. Our aims were to assess whether 1) an association between increased TIR and hypoglycemia exists, and 2) how time in hypoglycemia varies by PCR status. We analyzed 80 youth who were started on CGM shortly after T1D diagnosis and were followed for up to 1-year post diagnosis. TIR and hypoglycemia rates were determined by CGM data and retrospectively analyzed. PCR was defined as (visit glycated hemoglobin A1c) + (4*units/kg/day) less than 9. Youth were started on CGM 8.0 (interquartile range, 6.0-13.0) days post diagnosis. Time spent at less than 70 mg/dL remained low despite changes in TIR (highest TIR 74.6 ± 16.7%, 2.4 ± 2.4% hypoglycemia at 1 month post diagnosis; lowest TIR 61.3 ± 20.3%, 2.1 ± 2.7% hypoglycemia at 12 months post diagnosis). No events of severe hypoglycemia occurred. Hypoglycemia was rare and there was minimal difference for PCR vs non-PCR youth (54-70 mg/dL: 1.8% vs 1.2%, P = .04; < 54mg/dL: 0.3% vs 0.3%, P = .55). Approximately 50% of the time spent in hypoglycemia was in the 65 to 70 mg/dL range. As TIR gradually decreased over 12 months post diagnosis, hypoglycemia was limited with no episodes of severe hypoglycemia. Hypoglycemia rates did not vary in a clinically meaningful manner by PCR status. With CGM being started earlier, consideration needs to be given to modifying CGM hypoglycemia education, including alarm settings. These data support a trial in the year post diagnosis to determine alarm thresholds for youth who wear CGM.

Identifiants

pubmed: 34265059
pii: 6321980
doi: 10.1210/clinem/dgab522
pmc: PMC8530719
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Glycated Hemoglobin A 0
Hypoglycemic Agents 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3239-3247

Subventions

Organisme : NIDDK NIH HHS
ID : K12 DK122550
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30DK116074
Pays : United States
Organisme : NIDDK NIH HHS
ID : R18 DK122422
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK116074
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4356-4364
pubmed: 31127824
Pediatr Diabetes. 2020 Aug;21(5):808-813
pubmed: 32304129
Curr Diab Rep. 2018 Sep 26;18(11):114
pubmed: 30259309
Pediatr Diabetes. 2018 Oct;19 Suppl 27:178-192
pubmed: 29869358
Diabetes Care. 2019 Sep;42(9):1630-1636
pubmed: 31213467
Diabetes Care. 2018 Oct;41(10):2155-2161
pubmed: 30089663
Diabetologia. 2020 Dec;63(12):2501-2520
pubmed: 33047169
Diabetes Care. 2020 Nov 2;:
pubmed: 33139407
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33514530
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
J Clin Endocrinol Metab. 2013 Aug;98(8):3411-9
pubmed: 23760624
Diabetes Care. 2021 Jan;44(1):133-140
pubmed: 32938745
J Endocr Soc. 2017 Nov 20;1(12):1445-1460
pubmed: 29344577
Diabet Med. 2021 Aug;38(8):e14567
pubmed: 33772862
J Clin Endocrinol Metab. 2020 Aug 1;105(8):
pubmed: 32382736
Diabetes Care. 2021 Apr;44(4):969-975
pubmed: 33579715
BMC Endocr Disord. 2018 Feb 20;18(1):12
pubmed: 29458348
Diabetes. 2008 Nov;57(11):2883-8
pubmed: 18971435
J Diabetes Sci Technol. 2021 May;15(3):630-635
pubmed: 32172603
Diabetes Care. 2021 Jan;44(Suppl 1):S180-S199
pubmed: 33298424
Diabetes Technol Ther. 2019 Feb;21(2):81-85
pubmed: 30575414
Diabetes Care. 2016 Apr;39(4):555-62
pubmed: 26884472
Front Endocrinol (Lausanne). 2020 Jul 09;11:360
pubmed: 32733375
Diabetes Care. 2014 Jul;37(7):1885-91
pubmed: 24804697
Diabetes Care. 2020 Jan;43(1):e3-e4
pubmed: 31558548
Diabetes Technol Ther. 2019 Aug;21(8):456-461
pubmed: 31180244
Diabetologia. 2014 Aug;57(8):1578-85
pubmed: 24893863
J Diabetes Sci Technol. 2021 Sep;15(5):1093-1097
pubmed: 32522029
Diabetes Care. 2017 Feb;40(2):181-187
pubmed: 27899489
Diabet Med. 2018 Apr;35(4):409-418
pubmed: 29247556
Diabetes Care. 2021 Feb;44(2):301-312
pubmed: 33431422
Diabetes Care. 2011 Apr;34(4):795-800
pubmed: 21335621
Diabetes Care. 2018 Sep;41(9):2026-2044
pubmed: 30093549
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84
pubmed: 33298417
Diabetes Care. 2021 Jan;44(1):14-16
pubmed: 33444165
J Diabetes Sci Technol. 2013 May 01;7(3):789-94
pubmed: 23759412
Pediatr Diabetes. 2017 Nov;18(7):643-650
pubmed: 27878914
Diabetes Care. 2008 Nov;31(11):2108-9
pubmed: 18689694
Pediatr Diabetes. 2020 Nov;21(7):1301-1309
pubmed: 32681582
Pediatr Diabetes. 2018 Oct;19 Suppl 27:105-114
pubmed: 30058221
Curr Diab Rep. 2016 Aug;16(8):77
pubmed: 27370530
Diabetes Obes Metab. 2018 Aug;20(8):1812-1816
pubmed: 29652110
Diabetes Care. 2021 May 17;:
pubmed: 34001535
Diabetes Care. 2009 Aug;32(8):1384-90
pubmed: 19435955
Pediatr Diabetes. 2006 Apr;7(2):101-7
pubmed: 16629716
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
Diabetes Technol Ther. 2020 Mar;22(3):169-173
pubmed: 31596132
Diabetes Care. 1993 Jan;16(1):125-32
pubmed: 8422766
Diabetes Metab Syndr Obes. 2011;4:337-46
pubmed: 21969805
J Diabetes Sci Technol. 2019 Jul;13(4):763-773
pubmed: 30666883
Diabetes Care. 2015 Jul;38(7):1197-204
pubmed: 26049549

Auteurs

Ananta Addala (A)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.

Dessi P Zaharieva (DP)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.

Angela J Gu (AJ)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.
Department of Management Science and Engineering, Stanford University, Stanford, California, USA.

Priya Prahalad (P)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.
Stanford Diabetes Research Center, Stanford, California, USA.

David Scheinker (D)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.
Department of Management Science and Engineering, Stanford University, Stanford, California, USA.
Stanford Diabetes Research Center, Stanford, California, USA.

Bruce Buckingham (B)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.
Stanford Diabetes Research Center, Stanford, California, USA.

Korey K Hood (KK)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.
Stanford Diabetes Research Center, Stanford, California, USA.

David M Maahs (DM)

Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.
Stanford Diabetes Research Center, Stanford, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH